Dunlee unveiled its new oncology bundles for the first time this year, launched at the 2022 European Congress of Radiology

July 25, 2022 —  Dunlee unveiled its new oncology bundles for the first time this year, launched at the 2022 European Congress of Radiology. Onsite at the conference, attendees were able to view bundles, which combine components that have been tested and verified to work together so clinicians can offer state-of-the-art onboard Cone Beam CT (CBCT) in facilities. As cancer cases rise globally, an estimated 60% of new patients will need some form of radiation therapy, but only 25% of those patients will receive treatment, either because the equipment is not available or because treatment is too costly. It is estimated that by 2030, if every patient who needs radiotherapy has access to it, almost one million more lives will be saved every year worldwide. Image guidance has been a major breakthrough in efforts to make radiation therapy more precise, because it enables physicians to take images immediately before treatment while the patient is in the treatment position. 

The oncology bundles include: 

· X-ray Tubes, which customers rely on our products’ small focal spot size to enable high resolution imaging 

· X-ray Flat Panel Detectors, providing excellent soft tissue visualization to identify tumor borders, a large field of view, fast frame speed of up to 150 frames-per-second, sharp images, and minimal motion artifacts 

· Anti-scatter Grids, which significantly improve soft tissue visibility and uniformity without the need to increase imaging dose 

· Cables, including all modifications customers need for efficient integration into their linear accelerator 

Dunlee offers two types of bundles, that combine successful and proven imaging solutions with the specific needs of image guidance in therapy.: 

· DA1094 X-ray Tube Bundle, which consists of a flat panel detector, DA 1094 X-ray tube, anti-scatter grid and high voltage cables 

· Grid and Detector Bundle, which combines a state-of-the-art anti-scatter grid with the Dunlee XD-300 Detector for excellent soft tissue visualization and fast operation 

· Dunlee Solutions+, Dunlee’s service portfolio, which supports customers in every step of product development, from system definition through operation 

For more information: https://www.dunlee.com/ 

Find more ECR22 coverage here  

Related Content

News | Radiation Therapy

August 19, 2022 — Recently published research out of VCU Massey Cancer Center demonstrated that cancer patients who live ...

Time August 19, 2022
arrow
News | Breast Imaging

August 19, 2022 — The Christ Hospital Health Network, known for providing the best, most compassionate care for its ...

Time August 19, 2022
arrow
News | X-Ray

August 17, 2022 — The Institute of Human Virology in Nigeria (IHVN) has announced their partnership with Fujifilm, the ...

Time August 17, 2022
arrow
News | Prostate Cancer

August 16, 2022 — A new study published by University of Kentucky Markey Cancer Center researchers suggests that the ...

Time August 16, 2022
arrow
News | Breast Imaging

August 15, 2022 — Brainlab announced the first group of breast cancer patients treated in United States with the ...

Time August 15, 2022
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

Did you know that Imaging Technology News (ITN) maintains more than 40 comparison charts of product specifications from ...

Time August 12, 2022
arrow
News | ASTRO

August 12, 2022 — The American Society for Radiation Oncology (ASTRO) today expressed its support for President Joseph R ...

Time August 12, 2022
arrow
News | Lung Imaging

August 10, 2022 — Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 ...

Time August 10, 2022
arrow
News | Prostate Cancer

August 9, 2022 — Bot Image, an Omaha-based MRI medical device company has developed an AI-driven medical device CAD ...

Time August 09, 2022
arrow
News | Breast Imaging

August 8, 2022 — The U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV ...

Time August 08, 2022
arrow
Subscribe Now